Structure and function of mesothelial cells

Peritoneal Carcinomatosis: A Multidisciplinary Approach

Volumn , Issue , 2007, Pages 1-19

  Mutsaers, Steven E ^a   Wilkosz, Sylwia ^a  

^a SIR CHARLES GAIRDNER HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84892815669     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-48993-3_1     Document Type: Chapter

References (100)

1. Whitaker D, Papadimitriou JM, Walters MN (1982) The mesothelium and its reactions: a review. Crit Rev Toxicol 10(2):81-144
2. Mutsaers SE, Whitaker D, Papadimitriou JM (1996) Changes in the concentration of microvilli on the free surface of healing mesothelium are associated with alterations in surface membrane charge. J Pathol 180(3):333-339
3. Bird SD (2004) Mesothelial primary cilia of peritoneal and other serosal surfaces. Cell Biol Int 28(2):151-159
4. Fedorko ME, Hirsch JG (1971) Studies on transport of macromolecules and small particles across mesothelial cells of the mouse omentum. I. Morphologic aspects. Exp Cell Res 69(1):113-127
5. Kluge T, Hovig T (1967) The ultrastructure of human and rat pericardium. II. Intercellular spaces and junctions. Acta Pathol Microbiol Scand 71(4):547-563
6. Mutsaers SE, Whitaker D, Papadimitriou JM (2002) Stimulation of mesothelial cell proliferation by exudate macrophages enhances serosal wound healing in a murine model. Am J Pathol 160(2):681-692
7. Albertine KH, Wiener-Kronish JP, Roos PJ, Staub NC (1982) Structure, blood supply, and lymphatic vessels of the sheep's visceral pleura. Am J Anat 165(3):277-294
8. Nakatani T, Ohtani O, Tanaka S (1996) Lymphatic stomata in the murine diaphragmatic peritoneum: the timing of their appearance and a map of their distribution. Anat Rec 244(4):529-539
9. LaRocca PJ, Rheinwald JG (1984) Coexpression of simple epithelial keratins and vimentin by human mesothelium and mesothelioma in vivo and in culture. Cancer Res 44(7):2991-2999
10. Yanez-Mo M, Lara-Pezzi E, Selgas R, Ramirez-Huesca M, Dominguez-Jimenez C, Jimenez-Heffernan JA, et al (2003) Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med 348(5): 403-413
11. Yang AH, Chen JY, Lin JK (2003) Myofibroblastic conversion of mesothelial cells. Kidney Int 63(4):1530-1539
12. Wilm B, Ipenberg A, Hastie ND, Burch JB, Bader DM (2005) The serosal mesothelium is a major source of smooth muscle cells of the gut vasculature. Development 132(23):5317-5328
13. Herrick SE, Mutsaers SE (2004) Mesothelial progenitor cells and their potential in tissue engineering. Int J Biochem Cell Biol 36(4):621-642
14. Hills BA (2000) Role of surfactant in peritoneal dialysis. Perit Dial Int 20(5):503-515
15. Michailova KN (2004) Mesothelial lamellar bodies in norm and experimental conditions. Transmission and scanning electron microscopic observations on the peritoneum, pleura and pericardium. Anat Embryol (Berl) 208(4):301-309
16. Andrews PM, Porter KR (1973) The ultrastructural morphology and possible functional significance of mesothelial microvilli. Anat Rec 177(3):409-426
17. Heldin P, Pertoft H (1993) Synthesis and assembly of the hyaluronancontaining coats around normal human mesothelial cells. Exp Cell Res 208(2):422-429
18. Wang NS (1974) The regional difference of pleural mesothelial cells in rabbits. Am Rev Respir Dis 110(5):623-633
19. Topley N (1995) The host's initial response to peritoneal infection: the pivotal role of the mesothelial cell. Perit Dial Int 15(2):116-117
20. Jonjic N, Peri G, Bernasconi S, Sciacca FL, Colotta F, Pelicci P, et al (1992) Expression of adhesion molecules and chemotactic cytokines in cultured human mesothelial cells. J Exp Med 176(4):1165-1174
21. Visser CE, Tekstra J, Brouwer-Steenbergen JJ, Tuk CW, Boorsma DM, Sampat-Sardjoepersad SC, et al (1998) Chemokines produced by mesothelial cells: huGRO-alpha, IP-10, MCP-1 and RANTES. Clin Exp Immunol 112(2):270-275
22. Katayama H, Yokoyama A, Kohno N, Sakai K, Hiwada K, Yamada H, et al (2002) Production of eosinophilic chemokines by normal pleural mesothelial cells. Am J Respir Cell Mol Biol 26(4):398-403
23. Foussat A, Balabanian K, Amara A, Bouchet-Delbos L, Durand-Gasselin I, Baleux F, et al (2001) Production of stromal cell-derived factor 1 by mesothe-lial cells and effects of this chemokine on peritoneal B lymphocytes. Eur J Immunol 31(2):350-359
24. Nasreen N, Mohammed KA, Hardwick J, Van Horn RD, Sanders KL, Doer-schuk CM, et al (2001) Polar production of interleukin-8 by mesothelial cells promotes the transmesothelial migration of neutrophils: role of intercellular adhesion molecule-1. J Infect Dis 183(11):1638-1645
25. Ross JA, Ansell I, Hjelle JT, Anderson JD, Miller-Hjelle MA, Dobbie JW (1998) Phenotypic mapping of human mesothelial cells. Adv Pent Dial 14:25-30
26. Simsir A, Fetsch P, Mehta D, Zakowski M, Abati A (1999) E-cadherin, N-cadherin, and calretinin in pleural effusions: the good, the bad, the worthless. Diagn Cytopathol 20(3):125-130
27. Liang Y, Sasaki K (2000) Expression of adhesion molecules relevant to leukocyte migration on the microvilli of liver peritoneal mesothelial cells. Anat Rec 258(1):39-46
28. Bellingan GJ, Caldwell H, Howie SE, Dransfield I, Haslett C (1996) In vivo fate of the inflammatory macrophage during the resolution of inflammation: inflammatory macrophages do not die locally, but emigrate to the draining lymph nodes. J Immunol 157(6):2577-2585
29. Bellingan GJ, Xu P, Cooksley H, Cauldwell H, Shock A, Bottoms S, et al (2002) Adhesion molecule-dependent mechanisms regulate the rate of macro-phage clearance during the resolution of peritoneal inflammation. J Exp Med 196(11):1515-1521
30. Valle MT, Degl'Innocenti ML, Bertelli R, Facchetti P, Perfumo F, Fenoglio D, et al (1995) Antigen-presenting function of human peritoneum mesothelial cells. Clin Exp Immunol 101(1):172-176
31. Hausmann MJ, Rogachev B, Weiler M, Chaimovitz C, Douvdevani A (2000) Accessory role of human peritoneal mesothelial cells in antigen presentation and T-cell growth. Kidney Int 57(2):476-486
32. Basok A, Shnaider A, Man L, Chaimovitz C, Douvdevani A (2001) CD40 is expressed on human peritoneal mesothelial cells and upregulates the production of interleukin-15 and RANTES. J Am Soc Nephrol 12(4):695-702
33. Mazar J, Agur T, Rogachev B, Ziv NY, Zlotnik M, Chaimovitz C, et al (2005) CD40 ligand (CD154) takes part in regulation of the transition to mononuclear cell dominance during peritonitis. Kidney Int 67(4):1340-1349
34. Lanfrancone L, Boraschi D, Ghiara P, Falini B, Grignani F, Peri G, et al (1992) Human peritoneal mesothelial cells produce many cytokines (granulo-(granulacyte colony-stimulating factor [CSF], granulocyte-monocyte-CSF, macrophage-CSF, interleukin-1 [IL-1], and IL-6) and are activated and stimulated to grow by IL-1. Blood 80(11):2835-2842
35. Topley N, Jorres A, Luttmann W, Petersen MM, Lang MJ, Thierauch KH, et al (1993) Human peritoneal mesothelial cells synthesize interleukin-6: induction by IL-1 beta and TNF alpha. Kidney Int 43(1):226-233
36. Xing Z, Gauldie J, Cox G, Baumann H, Jordana M, Lei XF, et al (1998) IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 101(2):311-320
37. Choe N, Tanaka S, Kagan E (1998) Asbestos fibers and interleukin-1 upregu-late the formation of reactive nitrogen species in rat pleural mesothelial cells. Am J Respir Cell Mol Biol 19(2):226-236
38. Hott JW, Godbey SW, Antony VB (1994) Mesothelial cell modulation of pleural repair: thrombin stimulated mesothelial cells release prostaglandin E2. Prostaglandins Leukot Essent Fatty Acids 51(5):329-335
39. Mutsaers SE, Bishop JE, McGrouther G, Laurent GJ (1997) Mechanisms of tissue repair: from wound healing to fibrosis. Int J Biochem Cell Biol 29(1): 5-17
40. Warn R, Harvey P, Warn A, Foley-Comer A, Heldin P, Versnel M, et al (2001) HGF/SF induces mesothelial cell migration and proliferation by autocrine and paracrine pathways. Exp Cell Res 267(2):258-266
41. Rennard SI, Jaurand MC, Bignon J, Kawanami O, Ferrans VJ, Davidson J, et al (1984) Role of pleural mesothelial cells in the production of the sub-mesothelial connective tissue matrix of lung. Am Rev Respir Dis 130(2):267-274
42. Saed GM, Zhang W, Chegini N, Holmdahl L, Diamond MP (1999) Alteration of type I and III collagen expression in human peritoneal mesothelial cells in response to hypoxia and transforming growth factor-beta1. Wound Repair Regen 7(6):504-510
43. Perfumo F, Altieri P, Degl'Innocenti ML, Ghiggeri GM, Caridi G, Trivelli A, et al (1996) Effects of peritoneal effluents on mesothelial cells in culture: cell proliferation and extracellular matrix regulation. Nephrol Dial Transplant 11(9):1803-1809
44. Margetts PJ, Kolb M, Galt T, Hoff CM, Shockley TR, Gauldie J (2001) Gene transfer of transforming growth factor-beta1 to the rat peritoneum: effects on membrane function. J Am Soc Nephrol 12(10):2029-2039
45. Ma C, Tarnuzzer RW, Chegini N (1999) Expression of matrix metallopro-teinases and tissue inhibitor of matrix metalloproteinases in mesothelial cells and their regulation by transforming growth factor-beta1. Wound Repair Regen 7(6):477-485
46. Yung S, Thomas GJ, Stylianou E, Williams JD, Coles GA, Davies M (1995) Source of peritoneal proteoglycans. Human peritoneal mesothelial cells synthesize and secrete mainly small dermatan sulfate proteoglycans. Am J Pathol 146(2):520-529
47. Howe A, Aplin AE, Alahari SK, Juliano RL (1998) Integrin signaling and cell growth control. Curr Opin Cell Biol 10(2):220-231
48. Morrissey JH, Gregory SA, Mackman N, Edgington TS (1989) Tissue factor regulation and gene organization. Oxf Surv Eukaryot Genes 6:67-84
49. Iakhiaev A, Idell S (2006) Activation and degradation of protein C by primary rabbit pleural mesothelial cells. Lung 184(2):81-88
50. Ivarsson ML, Holmdahl L, Falk P, Molne J, Risberg B (1998) Characterization and fibrinolytic properties of mesothelial cells isolated from peritoneal lavage. Scand J Clin Lab Invest 58(3):195-203
51. Tietze L, Elbrecht A, Schauerte C, Klosterhalfen B, Amo-Takyi B, Gehlen J, et al (1998) Modulation of pro-and antifibrinolytic properties of human peritoneal mesothelial cells by transforming growth factor beta1 (TGF-beta1), tumor necrosis factor alpha (TNF-alpha) and interleukin 1beta (IL-1beta). Thromb Haemost 79(2):362-370
52. Falk K, Bjorquist P, Stromqvist M, Holmdahl L (2001) Reduction of experimental adhesion formation by inhibition of plasminogen activator inhibitor type 1. Br J Surg 88(2):286-289
53. Yonemura Y, Endou Y, Fujita H, Fushida S, Bandou E, Taniguchi K, et al (2000) Role of MMP-7 in the formation of peritoneal dissemination in gastric cancer. Gastric Cancer 3(2):63-70
54. Cunliffe WJ, Sugarbaker PH (1989) Gastrointestinal malignancy: rationale for adjuvant therapy using early postoperative intraperitoneal chemotherapy. Br J Surg 76(10):1082-1090
55. Sugarbaker PH (1991) A perspective on clinical research strategies in carcinoma of the large bowel. World J Surg 15(5):609-916
56. van den Tol PM, van Rossen EE, van Eijck CH, Bonthuis F, Marquet RL, Jeekel H (1998) Reduction of peritoneal trauma by using nonsurgical gauze leads to less implantation metastasis of spilled tumor cells. Ann Surg 227(2):242-248
57. Tsujimoto H, Hagiwara A, Shimotsuma M, Sakakura C, Osaki K, Sasaki S, et al (1996) Role of milky spots as selective implantation sites for malignant cells in peritoneal dissemination in mice. J Cancer Res Clin Oncol 122(10):590-595
58. van der Wal BC, Hofland LJ, Marquet RL, van Koetsveld PM, van Rossen ME, van Eijck CH (1997) Paracrine interactions between mesothelial and colon-carcinoma cells in a rat model. Int J Cancer 73(6):885-890
59. van Grevenstein WM, Hofland LJ, Jeekel J, van Eijck CH (2006) The expression of adhesion molecules and the influence of inflammatory cytokines on the adhesion of human pancreatic carcinoma cells to mesothelial monolayers. Pancreas 32(4):396-402
60. van Rossen ME, Hofland LJ, van den Tol MP, van Koetsveld PM, Jeekel J, Marquet RL, et al (2001) Effect of inflammatory cytokines and growth factors on tumour cell adhesion to the peritoneum. J Pathol 193(4):530-537
61. Ziprin P, Ridgway PF, Pfistermuller KL, Peck DH, Darzi AW (2003) ICAM-1 mediated tumor-mesothelial cell adhesion is modulated by IL-6 and TNF-alpha: a potential mechanism by which surgical trauma increases peritoneal metastases. Cell Commun Adhes 10(3):141-154
62. Ziprin P, Alkhamesi NA, Ridgway PF, Peck DH, Darzi AW (2004) Tumour-expressed CD43 (sialophorin) mediates tumour-mesothelial cell adhesion. Biol Chem 385(8):755-761
63. Alkhamesi NA, Ziprin P, Pfistermuller K, Peck DH, Darzi AW (2005) ICAM-1 mediated peritoneal carcinomatosis, a target for therapeutic intervention. Clin Exp Metastasis 22(6):449-459
64. Burleson KM, Casey RC, Skubitz KM, Pambuccian SE, Oegema TR, Jr., Skubitz AP (2004) Ovarian carcinoma ascites spheroids adhere to extracellular matrix components and mesothelial cell monolayers. Gynecol Oncol 93(1):170-181
65. Lessan K, Aguiar DJ, Oegema T, Siebenson L, Skubitz AP (1999) CD44 and beta1 integrin mediate ovarian carcinoma cell adhesion to peritoneal mesothelial cells. Am J Pathol 154(5):1525-1537
66. Ahmed N, Riley C, Rice G, Quinn M (2005) Role of integrin receptors for fibronectin, collagen and laminin in the regulation of ovarian carcinoma functions in response to a matrix microenvironment. Clin Exp Metastasis 22(5):391-402
67. Casey RC, Skubitz AP (2000) CD44 and beta1 integrins mediate ovarian carcinoma cell migration toward extracellular matrix proteins. Clin Exp Metastasis 18(1):67-75
68. Takatsuki H, Komatsu S, Sano R, Takada Y, Tsuji T (2004) Adhesion of gastric carcinoma cells to peritoneum mediated by alpha3beta1 integrin (VLA-3). Cancer Res 64(17):6065-6070
69. Kawamura T, Endo Y, Yonemura Y, Nojima N, Fujita H, Fujimura T, et al (2001) Significance of integrin alpha2/beta1 in peritoneal dissemination of a human gastric cancer xenograft model. Int J Oncol 18(4):809-815
70. Zeng C, Toole BP, Kinney SD, Kuo JW, Stamenkovic I (1998) Inhibition of tumor growth in vivo by hyaluronan oligomers. Int J Cancer 77(3):396-401
71. Catterall JB, Gardner MJ, Jones LM, Turner GA (1997) Binding of ovarian cancer cells to immobilized hyaluronic acid. Glycoconj J 14(5):647-649
72. Catterall JB, Jones LM, Turner GA (1999) Membrane protein glycosylation and CD44 content in the adhesion of human ovarian cancer cells to hyaluronan. Clin Exp Metastasis 17(7):583-591
73. Kayastha S, Freedman AN, Piver MS, Mukkamalla J, Romero-Guittierez M, Werness BA (1999) Expression of the hyaluronan receptor, CD44S, in epithelial ovarian cancer is an independent predictor of survival. Clin Cancer Res 5(5):1073-1076
74. Harada N, Mizoi T, Kinouchi M, Hoshi K, Ishii S, Shiiba K, et al (2001) Introduction of antisense CD44S CDNA down-regulates expression of overall CD44 isoforms and inhibits tumor growth and metastasis in highly metastatic colon carcinoma cells. Int J Cancer 91(1):67-75
75. Jones LM, Gardner MJ, Catterall JB, Turner GA (1995) Hyaluronic acid secreted by mesothelial cells: a natural barrier to ovarian cancer cell adhesion. Clin Exp Metastasis 13(5):373-380
76. Breborowicz A, Oreopoulos DG (2005) Is normal saline harmful to the peritoneum? Perit Dial Int 25 Suppl 4:S67-70
77. Yao V, Platell C, Hall JC (2005) Lavage enhances the production of proinflammatory mediators by peritoneal mesothelial cells in an experimental model. Dis Colon Rectum 48(3):560-566
78. Symowicz J, Adley BP, Woo MM, Auersperg N, Hudson LG, Stack MS (2005) Cyclooxygenase-2 functions as a downstream mediator of lysophosphatidic acid to promote aggressive behavior in ovarian carcinoma cells. Cancer Res 65(6):2234-2242
79. Ren J, Xiao YJ, Singh LS, Zhao X, Zhao Z, Feng L, et al (2006) Lysophosphatidic acid is constitutively produced by human peritoneal mesothelial cells and enhances adhesion, migration, and invasion of ovarian cancer cells. Cancer Res 66(6):3006-3014
80. Sako A, Kitayama J, Shida D, Suzuki R, Sakai T, Ohta H, et al (2006) Lysophosphatidic acid (LPA)-induced vascular endothelial growth factor (VEGF) by mesothelial cells and quantification of host-derived VEGF in malignant ascites. J Surg Res 130(1):94-101
81. Mizutani K, Kofuji K, Shirouzu K (2000) The significance of MMP-1 and MMP-2 in peritoneal disseminated metastasis of gastric cancer. Surg Today 30(7):614-621
82. Burleson KM, Hansen LK, Skubitz AP (2004) Ovarian carcinoma spheroids disaggregate on type I collagen and invade live human mesothelial cell monolayers. Clin Exp Metastasis 21(8):685-697
83. Hirashima Y, Kobayashi H, Suzuki M, Tanaka Y, Kanayama N, Terao T (2003) Transforming growth factor-beta1 produced by ovarian cancer cell line HRA stimulates attachment and invasion through an up-regulation of plasminogen activator inhibitor type-1 in human peritoneal mesothelial cells. J Biol Chem 278(29):26793-26802
84. Falk P, Ma C, Chegini N, Holmdahl L (2000) Differential regulation of mesothelial cell fibrinolysis by transforming growth factor beta 1. Scand J Clin Lab Invest 60(6):439-447
85. Taniguchi S (2005) Suppression of cancer phenotypes through a multifunctional actin-binding protein, calponin, that attacks cancer cells and simultaneously protects the host from invasion. Cancer Sci 96(11):738-746
86. Taniguchi S, Takeoka M, Ehara T, Hashimoto S, Shibuki H, Yoshimura N, et al (2001) Structural fragility of blood vessels and peritoneum in calponin h1-deficient mice, resulting in an increase in hematogenous metastasis and peritoneal dissemination of malignant tumor cells. Cancer Res 61(20):7627-7634
87. Hashimoto S, Takeoka M, Taniguchi S (2003) Suppression of peritoneal dissemination through protecting mesothelial cells from retraction by cancer cells. Int J Cancer 107(4):557-563
88. Hayashi K, Saga H, Chimori Y, Kimura K, Yamanaka Y, Sobue K (1998) Differentiated phenotype of smooth muscle cells depends on signaling path-ways through insulin-like growth factors and phosphatidylinositol 3-kinase J Biol Chem 273(44):28860-28867
89. Baker EA, Gaddal SE, Aitken DG, Leaper DJ (2003) Growth factor profiles in intraperitoneal drainage fluid following colorectal surgery: relationship to wound healing and surgery. Wound Repair Regen 11(4):261-267
90. Hofer SO, Shrayer D, Reichner JS, Hoekstra HJ, Wanebo HJ (1998) Woundinduced tumor progression: a probable role in recurrence after tumor resection. Arch Surg 133(4):383-389
91. Whitworth MK, Sheen A, Rosa DD, Duff SE, Ryder D, Burumdayal A, et al (2006) Impact of laparotomy and liver resection on the peritoneal concentrations of fibroblast growth factor 2, vascular endothelial growth factor and hepatocyte growth factor. J Cancer Res Clin Oncol 132(1):41-44
92. Jiang W, Hiscox S, Matsumoto K, Nakamura T (1999) Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical implications in cancer. Crit Rev Oncol Hematol 29(3):209-248
93. Ayhan A, Ertunc D, Tok EC, Ayhan A (2005) Expression of the c-Met in advanced epithelial ovarian cancer and its prognostic significance. Int J Gynecol Cancer 15(4):618-623
94. Kaji M, Yonemura Y, Harada S, Liu X, Terada I, Yamamoto H (1996) Participation of c-met in the progression of human gastric cancers: anti-c-met oligonucleotides inhibit proliferation or invasiveness of gastric cancer cells. Cancer Gene Ther 3(6):393-404
95. Yashiro M, Chung YS, Inoue T, Nishimura S, Matsuoka T, Fujihara T, et al (1996) Hepatocyte growth factor (HGF) produced by peritoneal fibroblasts may affect mesothelial cell morphology and promote peritoneal dissemination. Int J Cancer 67(2):289-293
96. Khan KN, Masuzaki H, Fujishita A, Kitajima M, Hiraki K, Sekine I, et al (2005) Interleukin-6-and tumour necrosis factor alpha-mediated expression of hepatocyte growth factor by stromal cells and its involvement in the growth of endometriosis. Hum Reprod 20(10):2715-2723
97. Weng J, Mohan RR, Li Q, Wilson SE (1997) IL-1 upregulates keratinocyte growth factor and hepatocyte growth factor mRNA and protein production by cultured stromal fibroblast cells: interleukin-1 beta expression in the cornea. Cornea 16(4):465-471
98. Fujiwara H, Kubota T, Amaike H, Inada S, Takashima K, Atsuji K, et al (2005) Suppression of peritoneal implantation of gastric cancer cells by adenovirus vector-mediated NK4 expression. Cancer Gene Ther 12(2):206-216
99. Nevado J, Vallejo S, El-Assar M, Peiro C, Sanchez-Ferrer CF, Rodriguez-Manas L (2006) Changes in the human peritoneal mesothelial cells during aging. Kidney Int 69(2):313-322
100. Mutsaers SE (2004) The mesothelial cell. Int J Biochem Cell Biol 36(1):9-16